Sanofi said last week it had entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, a year after flagging ...

PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical ...

Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella. Sanofi said any further updates on the ...

On Friday, Sanofi said it’s in negotiations with the private equity firm Clayton Dubilier & Rice for the potential sale of a 50% controlling stake in the consumer business, named Opella.

Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare business, in a deal that could yield billions of dollars for the French ...

In France, pharmaceutical giant Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to a US private equity firm. The sale is estimated at around 15 ...

Sanofi SAN0.00%increase; green up pointing triangle said it entered into talks to sell a controlling stake in its consumer-health business to private-equity firm Clayton Dubilier & Rice ...

OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia ...